MDT
Medtronic plc. · Healthcare · Medical Devices
TECHSellZACKSHold
R500#306 today
$86.38
-0.07% today · -2.55% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- MDT −0.07% on the last session vs SPY +0.74%: −0.8 pts of stock-specific move.
- Aftermath, crossed below 200-day avg (Sep 29): After its 11 crosses below the 200-day average in the past 5 years, MDT typically lost 1.0% over the next week (median) and was higher only 36% of the time; half the outcomes fell between -2.9% and +0.3%. An ordinary week: +0.0%. Among S&P 500 stocks after crosses below the 200-day average, that ranks #460 of 497.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Key facts
- Market cap
- $110.5B
- Held by institutions
- 88.6%
- Short interest
- 1.4%
- 52-week range
- 73.31–106.33
- Analyst mean target
- —
- Next earnings
- Nov 17 est.
- Forward P/E
- 13.5
Recent events
Earnings ▲
1Q2027 results: EPS $1.45 vs $1.39 expected beat +$0.06 (+4.5%); next session +1.5% (+2.2 vs SPY)Earnings ▲
4Q2026 results: EPS $1.55 vs $1.54 expected beat +$0.01 (+0.6%); revenue $9.8B; next session +5.7% (+6.4 vs SPY)Earnings ▲
3Q2026 results: EPS $1.36 vs $1.34 expected beat +$0.02 (+1.9%); revenue $9.0B; next session -3.1% (-3.3 vs SPY)Earnings ▲
2Q2026 results: EPS $1.36 vs $1.31 expected beat +$0.05 (+3.5%); revenue $9.0B; next session +4.7% (+5.5 vs SPY)